Brought to you by 
Etex licenses Alphatec Spine rights to sell biomaterials
16 Nov 2009
Executive Summary
Biomaterials company Etex has licensed spinal device firm Alphatec Spine nonexclusive rights to market and sell its bone graft substitutes in the US and Europe, excluding Spain.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Implantable Devices
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Etex licenses Alphatec Spine rights to sell biomaterials
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice